Abstract
In 1964, M.A. Epstein and Barr (1964) and Pulvertaft (1964a) reported the first successful attempts to establish Continuous lymphoblastoid-cell lines (LCLs) from expiants of Burkitt lymphoma (BL). Subsequent electron-microscopic examination of thin sections of the EB1 Cell line revealed virus particles that were morphologically similar to the herpesvirus group (M.A. Epstein et al., 1964a). In lines derived shortly thereafter from other BL tumors (M.A. Epstein et al., 1964b; Stewart et al., 1965; Rabson et al., 1966; Minowada et al., 1967), viral particles resembling those found in EB1 cells were seen. Such particles were not confined to lines originating from BL tissue, but were also seen in a fraction of cells in lymphoid lines established from patients with various malignancies (Armstrong, 1966; Moore et al., 1966; Zeve et al., 1966), from patients with infectious mononucleosis (IM) (Pope, 1967; Diehl et al., 1968), and from apparently normal individuals (Moore et al., 1967).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, A., 1979, The state of the virus genome in transformed cells and its relationship to host Cell DNA, in: The Epstein-Ban Virus (M.A. Epstein and B.G. Achong, eds.), pp. 155–183, Springer-Verlag, Berlin, Heidelberg, New York.
Adams, R.A., Hellerstine, E.E., Pothier, L., Foley, G.E., Lazarus, H., and Stuart, A.B., 1971, Malignant potential of a Cell line isolated from the peripheral blood in infectious mononucleosis, Cancel 27:651–657.
Adams, R.A., Pothier, L., Hellerstein, E.E., and Boileau, G., 1973, Malignant immunoblastoma, immunoglobulin synthesis and the progression to leukemia in heterotransplanted acute lymphoblastic leukemia, Chronic lymphatic leukemia, lymphoma, and infectious mononucleosis, Cancel 31:1397–1407.
Alspaugh, M.A., and Tan, E.M., 1976, Serum antibody in rheumatoid arthritis reactive with a Cell associated antigen, Arthritis Rheum. 19:711–719.
Andersson, M., and Lindahl, T., 1976, EBV DNA in human lymphoid Cell lines: In vitro conversion, Virology 73:96–105.
Andiman, W., and Miller, G., 1978, Properties of Epstein-Barr virus transformed woolly monkey lymphocytes, Proc. Soc. Exp. Biol. Med. 157:489–493.
Anvret, M.A., and Miller, G., 1981, Copy number and location of Epstein-Barr viral genomes in neonatal human lymphocytes transformed after separation by size and treatment with mitogens, Virology 111:47–55.
Armstrong, D., 1966, Serial Cultivation of human leukemic cells, Proc. Soc. Exp. Biol. Med. 122:475–481.
Baumal, R., Bloom, B. and Scharff, M.D., 1971, Induction of long term lymphocyte lines from delayed hypersensitive human donors using specific antigen plus Epstein-Barr virus, Nature (London) New Biol. 230:20–21.
Bechet, J.M., Fialkow, P., Nilsson, K., and Klein, G., 1974, Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as Cell markers in human lymphoblastoid Cell lines, Exp. Cell Res. 89:275–282.
Belpomme, D., Minowada, J., and Moore, G.E., 1972, Are some human lymphoblastoid Cell lines established from leukemic tissues actually derived from normal leukocytes?, Cancer 30:282–287.
Benz, W., Siegel, P., and Baer, J., 1978, Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus, J. Virol. 27:475–482.
Berger, R., Bernheim, A., Weh, H.-F., Flandrin, G., Daniel, M.T., Broust, J.C., and Colbert, N., 1979, A new translocation in Burkitt’s tumor cells, Hum. Genet. 53:11–12.
Bernoco, D., Glade, P.R., Broder, S., Miggiano, V.C., Hirschhorn, K., and Ceppellini, R., 1969, Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro, Folia Haematol. 54:795–895.
Bird, A.G., and Britton, S., 1979, A new approach to the study of human B-lymphocyte function using an indirect plaque assay and a direct B Cell activator, Immunol. Rev. 45:41–67.
Bister, K., Yamamoto, N., and zur Hausen, H., 1979, Differential inducibility of Epstein-Barr virus in Cloned, non-producer Raji cells, Int. J. Cancer 23:818–825.
Blacklow, N.R., Watson, B.K., Miller, G., and Jacobson, B.M., 1971, Mononucleosis with heterophile antibodies and EB virus infection: Acquisition by an elderly patient in hospital, Am. J. Med. 51:549–552.
Bloom, A.D., Choi, K.W., and Lamb, B.J., 1971, Immunoglobulin production by human lymphocytoid lines and Clones: Absence of genic exclusion, Science 172:382–384.
Bodmer, W.F., Jones, E.A., Young, D., Goodfellow, P.N., Bodmer, J.G., Dick, H.M., and Steel, G.M., 1975, Serology of human la antigens detected in lymphoid lines: An analysis of the 6th workshop sera, in: Histocompatibility Testing (F. Kiessmeyer-Nielsen, ed.), pp. 677–684, Munksgaard, Cophehagen.
Bornkamm, G.W., Delius, H., Zimber, U., Hudewentz, J., and Epstein, M.A., 1980, Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs, J. Virol. 35:603–618.
Brodsky, A.L., and Hurd, E.R., 1974, Enhanced establishment of lymphoblastoid Cell lines with the Ficoll Hypaque density gradient, Proc. Soc. Exp. Biol. Med. 147:612–615.
Budzko, D.B., Lachmann, P.J., and McConnell, I., 1976, Activation of the alternative Complement pathway by lymphoblastoid Cell lines from patients with Burkitt’s lymphoma and infectious mononucleosis, Cell. Immunol. 22:98–109.
Catalano, M.A., Carson, D.A., Slovin, S.F., Richman, D.D., and Vaughan, J.H., 1979, Antibodies to Epstein-Barr virus determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis, Proc. Natl. Acad. Sci. U.S.A. 76:5825–5828.
Catalano, M.A., Carson, D.A., Niederman, J.D., Feorino, P., and Vaughan, J.H. 1980, Antibody to the rheumatoid arthritis nuclear antigen: Its relationship to in vivo Epstein-Barr virus infection, J. Clin. Invest. 65:1238–1242.
Chandra, S., Moore, G.E., and Brandt, P.M., 1968, Similarity between leukocyte Cultures from Cancerous and noncancerous human subjects: An electron microscopic study, Cancer Res. 28:1982–1989.
Chang, R., and Chang, Y., 1980, Activation of lymphocytes from Epstein-Barr virus-sero-negative donors by autologous Epstein-Barr virus-transformed cells, J. Infect. Dis. 142:156–162.
Chang, R.S., Hsieh, M.-W., and Blankenship, W., 1971, Initiation and establishment of lymphoid Cell lines from blood of healthy persons, J. Natl. Cancer Inst. 47:469–477.
Clarkson, B., 1967, Formal discussion: On the Cellular origins and distinctive features of Cultured Cell lines derived from patients with leukemias and lymphomas, Cancer Res. 26:2483–2488.
Clements, G.B., Klein, G., and Povey, S., 1975, Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma Cell line without detectable EBV DNA, Int. J. Cancer 16:125–133.
Coope, D., Heston, L., Brandsma, J., and Miller, 1979, Cross neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera, J. Immunol. 123:232–238.
Crawford, D.H., Epstein, M.A., Bornkamm, G.W., Achong, B.G., Finerty, S., and Thompson, J.L., 1979, Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal Carcinomas, Int. J. Cancer 24:294–302.
Crawford, D.H., Thomas, J.A., Janossy, G., Sweny, P., Fernando, O.N., Moorhead, J.F., and Thompson, J.H., 1980, Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in a patient with renal allograft, Lancet 1:1355–1356.
Crichton, W.B., Dick, H.M., and Steel, C.M., 1973, Detection of HL-A antigens on Cultured lymphoblastoid cells, Symp. Ser. Immunobiol. Standardization 18:11–115.
Dambaugh, T., Nkrumah, F.K., Biggar, R.J., and Kieff, E., 1979, Epstein-Barr virus RNA in Burkitt tumor tissue, Cell 16:313–322.
Deal, D.R., Gerber, P., and Chisar, F.V., 1971, Heterotransplantation of two human lymphoid Cell lines transformed in vitro by Epstein-Barr virus, J. Natl. Cancer Inst. 47:771–780.
Delius, H., and Bornkamm, G.W., 1978, Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a non-transforming virus by partial denaturation mapping of their DNAs, J. Virol. 27:81–89.
De Thé, G., Ho, H.C., Kwan, H.C., Desgranges, C., and Favre, M.C., 1970, Nasopharyngeal carcinoma (NPC). 1. Types of Cultures derived from tumor biopsies and nontumor tissues of Chinese patients with special reference to lymphoblastoid transformation, Int. J. Cancer 6:189–206.
De Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P., and Henle, W., 1978, Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study, Nature (London) 274:756–761.
Dick, H.M., Steel, C.M., Crichton, W.B., and Hutton, M.M., 1973, Anomalous reactivity of some HL-A typing sera, Symp. Ser. Immunobiol. Standardization 18:116–123.
Dick, H.M., Bodmer, W.F., Bodmer, J.G., Steel, C.M., Crichton, W.B., and Evans, J., 1975, HL-A typing of lymphoblastoid Cell lines, in: Histocompatibility Testing (F. Kiessmeyer-Nielsen, ed., pp. 671–676, Munksgaard, Copenhagen.
Diehl, V., Henle, W., and Kohn, G., 1968, Demonstration of a herpes group virus in Cultures of peripheral leucocytes from patients with infectious mononucleosis, J. Virol. 2:663–669.
Einhorn, L., and Ernberg, I., 1978, Induction of EBNA precedes the first Cellular S-phase after EBV infection of human lymphocytes, Int. J. Cancer 21:157–160.
Einhorn, I., Steinitz, M., Yefenof, E., Ernberg, I., Bakacs, T., and Klein, G., 1978, Epstein-Barr Virus (EBV) receptors, Complement receptors, and EBV infectivity of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies, Cell Immunol. 35:43–58.
Epstein, A.L., Henle, W., Henle, G., Hewetson, J.F., and Kaplan, H.S., 1976, Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt’s lymphoma Cell lines, Proc. Natl. Acad. Sci. U.S.A. 73:228–232.
Epstein, M.A., and Achong, B.G., 1965, Fine structural organization of human lymphoblasts of a tissue Culture strain (EB1) from Burkitt’s lymphoma, J. Natl. Cancer Inst. 34:241–253.
Epstein, M.A., and Achong, B.C., 1968, Specific immunofluorescence test for the herpestype EB virus of Burkitt lymphoblasts authenticated by electron microscopy, J. Natl. Cancer Inst. 40:593–607.
Epstein, M.A., and Barr, Y.M., 1964, Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma, Lancet 1:252–253.
Epstein, M.A., and Barr, Y.M., 1965, Characteristics and mode of growth of a tissue Culture strain (EB1) of human lymphoblasts from Burkitt’s lymphoma, J. Natl. Cancer Inst. 34:231–240.
Epstein, M.A., Achong, B.G., and Barr, Y.M., 1964a, Virus particles in Cultured lymphoblasts from Burkitt’s lymphoma, Lancet 1:702–703.
Epstein, M.A., Barr, Y.M., and Achong, B.G., 1964b, A second virus-carrying tissue Culture strain (EB2) of lymphoblasts from Burkitt’s lymphoma, Pathol. Biol. (Paris) 12:1233–1234.
Epstein, M.A., Henle, G., Achong, B.G., and Barr, Y.M., 1965, Morphological and biological studies on a virus in Cultured lymphoblasts from Burkitt’s lymphoma, J. Exp. Med. 121:761–770.
Epstein, M.A., Achong, B.G., Barr, Y.M., Zajac, B., Henle, G., and Henle, W., 1966, Morphological and virological investigations on Cultured Burkitt tumor lymphoblasts (strain Raji), J. Natl. Cancer Inst. 37:547–555.
Epstein, M.A., Hunt, R., and Rabin, H., 1973, Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal, Int. J. Cancer 12:309–318.
Ernberg, I., 1982, Requirements for macromolecular synthesis during primary Epstein-Barr virus infection of lymphocytes (submitted).
Evans, A.S., Niederman, J.C., and McCollum, R.W., 1968, Seroepidemiologic studies of infectious mononucleosis with EB virus, N. Engl. J. Med. 279:1121–1127.
Evans, J., Steel, M., and Arthur, E., 1974, A hemagglutination inhibition technique for detection of immunoglobulins in supernatants of human lymphoblastoid Cell lines, Cell 3:153–158.
Fagraeus, A., Nilsson, K., Lidman, K., and Norberg, R., 1975, Reactivity of smooth-muscle antibodies, surface ultrastructure, and mobility in cells of human hematopoietic Cell lines, J. Natl. Cancer Inst. 55:783–789.
Fahey, J.L., and Finegold, I., 1967, Synthesis of immunoglobulins in human Cell lines, Cold Spring Harbor Symp. Quant. Biol. 32:283–289.
Fahey, J.L., Finegold, I., Rabson, A.S., and Manaker, R.A., 1966, Immunoglobulin synthesis in vitro by established human Cell lines, Science 152:1259–1261.
Fahey, J.L., Buell, D.N., and Sox, H.C., 1971, Proliferation and differentiation of lymphoid cells: Studies with human Cell lines and immunoglobulin synthesis, Ann. N. Y. Acad. Sci. 190:221–234.
Falk, L., Wolfe, L., Deinhardt, F., Paciga, J., Dombos, L., Klein, G., Henle W., and Henle, G., 1974, Epstein-Barr virus: Transformation of non-human primate lymphocytes in vitro, Int. J. Cancer 13:363–376.
Falk, L., Deinhardt, F., Wolfe, L., Johnson, D., Hilgers, J., and de Thé, G., 1976, Epstein-Barr virus: Experimental infection of Callothrix jacchus marmosets, Int. J. Cancer 17:785–788.
Ferrone, S., Pellegrino, M.A., and Reisfeld, R.A., 1971, A rapid method for direct HL-A typing of Cultured lymphoid cells, J. Immunol. 107:613–615.
Fialkow, P.J., Klein, E., Klein, G., Clifford, P., and Singh, S., 1973, Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of Cellular origin in Burkitt lymphoma, J. Exp. Med. 138:89–102.
Finegold, I., Fahey, J.L., and Granger, H., 1967, Synthesis of immunoglobulins by human cell lines in tissue Culture, J. Immunol. 99:839–848.
Flier, S.J., Glade, P.R., Broder, S.W., and Hirschhorn, K., 1970, Lymphocyte stimulation by allogeneic and autochthonous Cultured lymphoid cells, Cell. Immunol. 1:596–602.
Frank, A., Andiman, W., and Miller, G., 1976, Epstein-Barr virus and non-human primates: Natural and experimental infection, Adv. Cancer Res. 23:171–210.
Fresen, K.O., and zur Hausen, H., 1976, Establishment of EBNA-expressing Cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains, Int. J. Cancer 17:161–166.
Fresen, K.-O., Merkt, B., Bornkamm, G.W., and zur Hausen, H., 1977, Heterogeneity of Epstein-Barr virus originating from P3HR-1 Cells. I. Studies on EBNA induction, Int. J. Cancer 19:317–323.
Fresen, K.-O., Cho, M.-S., and zur Hausen, H., 1978, Recovery of transforming EBV from non-producer cells after superinfection with non transforming P3HR-1 EBV, Int. J. Cancer 22:378–383.
Fresen, K.-O., Cho, M.-S., Gissmann, L., and zur Hausen, H., 1979, NC37-R1 Epstein-Barr virus (EBV), a possible recombinant between intracellular NC37 viral DNA and su- perinfecting P3HR-1 EBV, Intervirology 12:303–310.
Fu, S.M., and Hurley, J.N., 1979, Human Cell lines Containing Epstein-Barr virus but distinct from the Common B Cell lymphoblastoid lines, Proc. Natl. Acad. Sci. U.S.A. 76:6637.
Fukuhara, S., and Rowley, J.D., 1978, Chromosome 14 translocations in non-Burkitt lymphomas, Int. J. Cancer 22:14–21.
Fukuhara, S., Ueshima, Y., Shirakawa, S., Uchino, H., and Morikawa, S., 1979, 14q translocations, having a break point at 14q 13 in lymphoid malignancy, Int. J. Cancer 24:739–743.
Geier, S.G., and Cresswell, P., 1977, Rabbit antisera to human B Cell alloantigens: Effects on the mixed lymphocyte response, Cell. Immunol. 28:341–354.
Gerber, P., and Hoyer, B., 1971, Induction of Cellular DNA synthesis in human leukocytes by Epstein-Barr virus, Nature (London) 231:46–47.
Gerber, P., and Lucas, S., 1972, Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine, Proc. Soc. Exp. Biol. Med. 141:431–435.
Gerber, P., and Monroe, J.H., 1968, Studies on leukocytes growing in Continuous Culture derived from normal human donors, J. Natl. Cancer Inst. 40:855–864.
Gerber, P., Whang-Peng, J., and Monroe, J.H., 1969, Transformation and Chromosome changes induced by Epstein-Barr virus in normal human leukocyte Cultures, Proc. Natl. Acad. Sci. U.S.A. 63:740–747.
Gergely, L., Klein, G., and Ernberg, I., 1971, The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines, Int. J. Cancer 7:293–302.
Giovanella, B., Nilsson, K., Zech, L., Yim, O., Klein, G., and Stehlin, J., 1979, Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid Cell lines heterotransplanted into nude mice under immunologically privileged Conditions, Int. J. Cancer 24:103–113.
Glade, P.R., and Chessin, L.N., 1968, Infectious mononucleosis: Immunoglobulin synthesis by Cell lines, J. Clin. Invest. 47:2391–2401.
Glaser, R., and Nonoyama, M., 1974, Host Cell regulation of induction of Epstein-Barr virus, J. Virol. 14:174–176.
Glaser, R., and Rapp, F., 1972, Rescue of Epstein-Barr virus from somatic Cell hybrids of Burkitt lymphoblastoid cells, J. Virol. 10:288–296.
Golub, S.H., Svedmyr, E.A.J., Hewetson, J.F., and Klein, G., 1972, Cellular reactions against Burkitt lymphoma Cells. III. Effector Cell activity of leukocytes stimulated in vitro with autochthonous Cultured lymphoma cells, Int. J. Cancer 10:157–164.
Gordon, F., Hough, D., Karpas, A., and Smith, J.L., 1977, Immunoglobulin expression and synthesis by human haemic Cell lines, Immunology 32:559–565.
Graessman, A., Wolf, H., and Bornkamm, G.W., 1980, Expression of Epstein-Barr virus genes in different Cell types after microinjection of viral DNA, Proc. Natl. Acad. Sci. U.S.A. 77:433–436.
Greaves, M.F., Brown, G., and Rickinson, A.B., 1975, Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in Cultured lymphoid Cell lines and in the blood of patients with infectious mononucleosis, Clin. Immunol. Immunopathol. 3:514–524.
Green, S.S., and Sell, K.E., 1970, Mixed leukocyte stimulation of normal peripheral leukocytes by autologous lymphoblastoid cells, Science 170:989–999.
Gunven, P., Klein, G., Klein, E., Norin, T., and Singh, S., 1980, Surface immunoglobulins on Burkitt’s lymphoma biopsy cells from 91 patients, Int. J. Cancer 25:711–719.
Hampar, B., Derge, J.G., Martos, L.M., and Walker, J.L., 1972, Synthesis of Epstein-Barr virus after activation of the viral genome in a virus negative human lymphoblastoid cell (Raji) made resistant to five bromodeoxyuridine, Proc. Natl. Acad. Sci. U.S.A. 69:78–82.
Hampar, B., Derge, J.G., Nonoyama, M., Chang, S.Y., Tagameto, M.A., and Showalter, S.D., 1974, Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine, Virology 62:71–89.
Han, T., Moore, G.E., and Sokal, J., 1971, In vitro lymphocyte response to autologous cultured lymphoid cells, Proc. Soc. Exp. Biol. Med. 136:976–979.
Hanto, D., Frizzera, G., Purtilo, D., Sakamoto, K., Sullivan, J., Saemundsen, A., Klein, G., Simmons, R., and Najarian, J., 1981, Lymphoproliferative disorders in renal transplant recipients. II. A Clinical spectrum and evidence for the role of Epstein-Barr virus, Cancer Res. 41:4253–4261.
Hardy, E.A., Ling, N.R., and Knight, S., 1969, Exceptional lymphocyte stimulating Capacity of cells from lymphoid Cell lines, Nature (London) 223:511–512.
Henderson, E., Miller, G., Robinson, J., and Heston, L., 1977a, Efficiency of transformation of lymphocytes by Epstein-Barr virus, Virology 76:152–163.
Henderson, E., Robinson, J., Frank, A., and Miller, G., 1977b, Epstein-Barr virus transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light, Virology 82:196–205.
Henderson, E., Heston, L., Grogan, E., and Miller, G., 1978, Radio-biological inactivation of Epstein-Barr virus, J. Virol. 25:51–59.
Henderson, E., Long, W., and Ribecky, R., 1979, Effects of nucleoside analogs on Epstein-Barr virus induced transformation of human umbilical Cord leukocytes and Epstein-Barr virus expression in transformed cells, Antimicrob. Agents Chemother. 15:101–110.
Henle, G., and Henle, W., 1966, Immunofluorescence in cells derived from Burkitt’s lymphoma, J. Bactehol. 91:1248–1256.
Henle, G., and Henle, W., 1967, Immunofluorescence, interference and Complement fixation technics in the detection of the herpes-type virus in Burkitt tumor Cell lines, Cancer Res. 27:2442–2446.
Henle, G., Henle, W., and Diehl, V., 1968, Relation of Burkitt’s tumor-associated herpestype virus to infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 59:94–101.
Henle, G., Henle, W., Zajac, B., Pearson, G., Waubke, R., and Scriba, M., 1970, Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169:188–190.
Henle, W., and Henle, G., 1968, Effect of arginine-deficient media on the herpes-type virus associated with Cultured Burkitt tumor cells, J. Virol. 2:182–191.
Henle, W., Diehl, V., Kohn, G., zur Hausen, H., and Henle, G., 1967, Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells, Science 157:1065–1065.
Herberman, R.B., 1978, Natural Cell-mediated Cytotoxicity in nude mice, in: The Nude Mouse in Experimental and Clinical Research (J. Fogh and B.C. Giovanella, eds.), pp. 136–166, Academic Press, New York.
Heyden, H.W.V., and Heyden, D. v., 1974, Criteria for the differentiation of lymphoid Cell lines, Blut 24:323–334.
Hinuma, Y., and Grace, J.T., 1967, Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long term Cultures, Proc. Soc. Exp. Biol. Med. 124:107–111.
Hinuma, Y., and Katsuki, T., 1978, Colonies of EBNA-positive cells in soft agar from peripheral leukocytes of infectious mononucleosis patients, Int. J. Cancer 21:426.
Hinuma, Y., Konn, M., Yamaguchi, J., and Grace, J.T., Jr., 1967, Replication of herpes-type virus in a Burkitt lymphoma Cell line, J. Virol. 1:1203–1206.
Huang, C.C., and Moore, G.E., 1969, Chromosomes of 14 hematopoietic Cell lines derived from peripheral blood of persons with and without Chromosome anomalies, J. Natl. Cancer Inst. 43:1119–1128.
Huang, C.C., Imamura, T., and Moore, G.E., 1969, Chromosomes and Cloning efficiencies of hematopoietic Cell lines derived from patients with leukemia, melanoma, myeloma and Burkitt lymphoma, J. Natl. Cancer Inst. 43:1129–1146.
Huang, C.C., Minowada, J., Smith, R.T., and Osunkoya, B.O., 1970, Reevaluation of relationship between C Chromosome marker and Epstein-Barr virus: Chromosome and immunofluorescence analysis of 16 human hematopoietic Cell lines, J. Natl. Cancer Inst. 45:815–829.
Huber, C., Sundstrom, C.C., Nilsson, K., and Wigzell, H., 1976, Surface receptors on human haematopoietic Cell lines, Clin. Exp. Immunol. 25:367–376.
Humphreys, R.E., McCune, J.M., Chess, L., Herrman, H.C., Malenka, D.J., Mann, D.L., Parham, P., Schlossman, S.F., and Strominger, J.L., 1976, Isolation and immunologic characterization of a human B-lymphocyte specific, Cell surface antigen, J. Exp. Med. 144:98–112.
Hutt, L.M., Huang, Y.T., Dascomb, H.E., and Pagano, J.S., 1975, Enhanced destruction of lymphoid Cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis, J. Immunol. 115:243–248.
Ikeuchi, T., Minowada, J., and Strandberg, A.A., 1971, Chromosomal variability in ten cloned sublines of a newly established Burkitt’s lymphoma Cell line, Cancer 28:499–512.
Imamura, R., and Moore, G.W., 1968, Ability of human hematopoietic Cell lines to form Colonies in soft agar, Proc. Soc. Exp. Biol. Med. 128:1179–1183.
Iwakata, S., and Grace, J.T., Jr., 1964, Cultivation in vitro of myeloblasts from human leukemia N. Y. J. Med. 64:2279–2282.
Jarvis, J.E., Ball, G., Rickinson, A.B., and Epstein, M.A., 1974, Cytogenetic studies on human lymphoblastoid Cell lines from Burkitt’s lymphomas and other sources, Int. J. Cancer 14:716–721.
Jensen, F.C., Gwatkin, R.B.L., and Biggers, J.D., 1964, A simple Culture which allows simultaneous isolation of specific types of cells, Exp. Cell Res. 34:440–447.
Jondai, M., and Klein, G., 1973, Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes, J. Exp. Med. 138:1365–1378.
Jondal, M., Klein, G., Oldstone, M.B.A., Bokish, V., and Yefenof, E., 1976, An association between Complement and Epstein-Barr virus receptors on human lymphoid cells, Scand. J. Immunol. 5:401–410.
Joss, A.W.L., Evans, J., Veitch, D.T., Arthyr, E., and Steel, C.M., 1976, Haemagglutinins produced in vitro by human lymphoblastoid cells, J. Immunogenet. 3:323–328.
Junge, U., Hoekstra, J., and Deinhardt, F., 1971, Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte Cell line, J. Immunol. 106:1306–1315.
Kaiser-McCaw, B., Epstein, A.L., Kaplan, H.S., and Hecht, F., 1977, Chromosome 14 translocation in African and North American Burkitt’s lymphoma, Int. J. Cancer 19:482–486.
Katsuki, T., and Hinuma, Y., 1975, Characteristics of Cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus, Int. J. Cancer 15:203–210.
Katsuki, T., Hinuma, Y., Yamamoto, N., Aho, T., and Kumagai, K., 1977, Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus, Virology 83:287–294.
Katsuki, T., Hinuma, Y., Saito, T., Yamamoto, J., Hirashima, Y., Sudoh, H., Deguchi, M., and Motokawa, M., 1979, Simultaneous presence of EBNA-positive and Colony-forming cells in peripheral blood of patients with infectious mononucleosis, Int. J. Cancer 23:746–750.
Kintner, C.R., and Sugden, B., 1979, The structure of the termini of the DNA of Epstein-Barr virus, Cell 17:661–672.
Kirchner, H., Tosato, G., Blaese, M., Bruder, S., and Magrath, I., 1979, Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro, J. Immunol. 122:1310–1313.
Klein, E., Klein, G., Nadkarni, J.S., Wigzell, H., and Clifford, K., 1968, Surface IgM-kappa specificity on a Burkitt lymphoma Cell in vivo and in derived Culture lines, Cancer Res. 28:1300–1310.
Klein, G., 1975, Studies on the Epstein-Barr virus genome and the EBV-determined nuclear antigen in human malignant disease, Cold Spring Harbor Symp. Quant. Biol. 39:783–790.
Klein, G., 1979, The relationship of the virus to nasopharyngeal Carcinoma, in: The Epstein-Barr Virus (M.A. Epstein and B.G. Achong, eds.), pp. 339–350, Springer-Verlag, Berlin, Heidelberg, New York.
Klein, G., 1980, Immune and non-immune Control of neoplastic development: Contrasting effects of host and tumor evolution, Cancer 45:2486–2499.
Klein, G., Giovanella, B.C., Lindahl, T., Fialkow, P.J., Singh, S., and Stehlin, J.S., 1974a, Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated Carcinoma of the nasopharynx, Proc. Natl. Acad. Sci. U.S.A. 71:4737–4741.
Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menezes, J., Nilsson, K., and Sundstrom, C., 1974b, Continuous lymphoid Cell lines with Characteristics of B cells (bone marrow-derived) lacking the EBV genome and derived from 3 human lymphomas, Proc. Natl. Acad. Sci. U.S.A. 71:3283–3286.
Klein, G., Sugden, B., Leibold, W., and Menezes, J., 1974c, Infection of EBV-genome-negative and -positive human lymphoblastoid Cell lines with biologically different preparations of EBV, Intervirology 3:232–244.
Klein, G., Svedmyr, E., Jondal, M., and Person, P.O., 1976, EBV-determined nuclear antigen (EBNA)-positive cells in peripheral blood of infectious mononucleosis patients, Int. J. Cancer 17:21–26.
Klein, G., Yefenof, E., Falk, K., and Westman, A., 1978, Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor Complex in a series of sublines derived from the same original Burkitt’s lymphoma, Int. J. Cancel 21:552–560.
Klein, G., Hyman, R., and Trowbridge, I., 1979, Correlated expression of a B-lymphocyte-specific glycoprotein (gp 27/35) and the EBV receptor/C3 receptor Complex in sublines from the same Burkitt lymphoma, Int. J. Cancer 23:37–41.
Klein, G., Luka, J., and Zeuthan, J., 1980, Transformation induced by Epstein-Barr virus and the role of the nuclear antigen, Cold Spring Harbor Symp. Quant. Biol. 44:253–261.
Knight, S.C., Moore, G.E., and Clarkson, B.D., 1971, Stimulation of autochthonous lymphocytes by cells from normal and leukemic lines, Nature (London) 229:185–187.
Kohn, G., Mellman, W.J., Moorhead, P.S., Loftus, J., and Henle, G., 1967, Involvement of C group Chromosomes in five Burkitt lymphoma Cell lines, J. Natl. Cancer Inst. 38:209–222.
Kohn, G., Diehl, V., Mellman, W.J., Henle, W., and Henle, G., 1968, C-group Chromosome marker in long-term leucocyte Cultures, J. Natl. Cancer Inst. 41:795–804.
Kozbor, D., Steinitz, M., Klein, G., Koskimies, S., and Mäkalä, O., 1979, Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation, Scand. J. Immunol. 10:187–194.
Lai, P.K., Mackay-Scollay, E.M., and Alpers, M.P., 1973, Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid Cell line Carrying Epstein-Barr virus, J. Gen. Virol. 21:135–143.
Leibold, W., Huldt, G., Flanagan, T., Andersson, M., Dalens, M., Wright, D., Voiler, A., and Klein, G., 1976, Tumorigenicity of Epstein-Barr virus (EBV)-transformed lymphoid line cells in autologous squirrel monkeys, Int. J. Cancer 17:533–541.
Levitt, M., Shungu, D., and Henderson, E., 1980, Colony morphology, Cell growth and viral radiosensitivity as parameters for detecting strain differences in Epstein-Barr virus (EBV), Int. J. Cancer 26:509–515.
Lindahl, T., and Adams, A., 1976, Covalently Closed Circular duplex DNA of Epstein-Barr virus in a human lymphoid Cell line, J. Mol. Biol. 102:511–530.
Lindahl, T., Klein, G., Reedman, B.M., Johansson, B., Singh, S., 1974, Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies, Int. J. Cancer 13:764–772.
Lindblom, B., and Nilsson, K., 1973, HL-A antigens in established human Cell lines: International Symposium on HL-A Reagents, Symp. Ser. Immunobiol. Standardization 18:124–128.
Litwin, S.D., and Lin, P.K., 1976, Phenotypic heterogeneity for cells bearing surface immunoglobulin in human lymphoid lines, Cell. Immunol. 24:270–276.
Litwin, S.D., Hütteroth, T.H., Lin, P.K., Kennard, J., and Cleve, H., 1974a, Immunoglobulin expression of cells from human lymphoblastoid lines. I. Heavy and light Chain antigens of the Cell surface, J. Immunol. 113:661–667.
Litwin, S.D., Hütteroth, T.H., Lin, P.K., Kennard, J., and Cleve, H., 1974b, Immunoglobulin expression of cells from human lymphoblastoid lines. II. Interrelationship among surface, Cellular, and secreted immunoglobulins, J. Immunol. 113:668–672.
Luka, J., Kallin, B., and Klein, G., 1979, Induction of the Epstein-Barr Virus (EBV) Cycle in latently infected cells by n-butyrate, Virology 94:228–231.
Luka, J., Siegert, W., and Klein, G., 1977, Solubilization of the Epstein-Barr virus-determined nuclear antigen and its Characterization as a DNA-binding protein, J. Virol. 22:1–8.
Manolov, G., and Manolova, Y., 1972, Marker band in one Chromosome 14 from Burkitt lymphomas, Nature (London) 237:33–34.
Manolova, Y., Manolov, G., Kieler, J., Levan, A., and Klein, G., 1979, Genesis of the 14q+ marker in Burkitt’s lymphoma, Hereditas 90:5–10.
Mark, J., Ekedahl, C., and Dahlenfors, R., 1978, Characteristics of the banding patterns in non-Hodgkin and non-Burkitt lymphomas, Heieditas 88:229–242.
Marker, S.C., Ascher, N.L., Kalis, J.M., Simmons, R.L., Najarian, J.S., and Balfour, H.H., Jr., 1979, Epstein-Barr virus antibody responses and Clinical illness in renal transplant recipients, Surgery 85:433–440.
McCune, J.M., Humphreys, R.E., Yocum, R.R., and Strominger, J.L., 1975, Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 72:3206–3209.
McCune, J.M., Lingappa, V.R., Fu, S.M., Bloble, G., and Kunkel, H.G., 1980, Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translation products of human mu-chain, with identical N-termini and different C-termini, J. Exp. Med. 152:463–468.
Menezes, J., Jondal, M., Leibold, W., and Dorval, G., 1976, Epstein-Barr virus interactions with human lymphocyte subpopulations, virus adsorptions, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation, Infect. Immun. 13:303–310.
Menezes, J., Seigneurin, J.M., Patel, P., Bourkas, A., and Lenoir, G., 1977, Presence of Epstein-Barr virus receptors, but absence of virus penetration in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4), J. Virol. 22:816–821.
Miles, C.P., and O’Neill, F., 1967, Chromosome studies of 8 in vitro lines of Burkitt’s lymphoma, Cancer Res. 27:392–402.
Miles, C.P., O’Neill, F., Armstrong D., Clarkson, B., and Keane, J., 1968, Chromosome patterns of human leukocyte established Cell lines, Cancer Res. 28:481–490.
Miller, G., 1980, Biology of Epstein-Barr virus, in: Viral Oncology (G. Klein, ed.), pp. 713–737, Raven Press, New York.
Miller, G., and Lipman, M., 1973a, Release of infectious Epstein-Barr virus by transformed marmoset leukocytes, Proc. Natl. Acad. Sci. U.S.A. 70:190–194.
Miller, G., and Lipman, M., 1973b, Comparison of the yield of infectious virus from Clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus, J. Exp. Med. 138:1398–1412.
Miller, G., Enders, J.F., and Lisco, H.I., 1969, Establishment of lines from normal human blood leukocytes by Co-cultivation with a leukocyte line derived from a leukemic child, Proc. Soc. Exp. Biol. Med. 132:247–250.
Miller, G., Lisco, H., Kohn, H.L., and Stitt, D., 1971, Establishment of Cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody, Proc. Soc. Exp. Biol. Med. 137:1459–1465.
Miller, G., Robinson, J., Heston, L., and Lipman, M., 1974, Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference, Proc. Natl. Acad. Sci. U.S.A. 71:4006–4010.
Miller, G., Coope, D., Niederman, J., and Pagano, J., 1976, Biologic properties and viral surface antigens of Burkitt lymphoma and mononucleosis derived strains of Epstein-Barr virus released from transformed marmoset cells, J. Virol. 18:1071–1080.
Miller, G., Shope, T., Coope, D., Waters, L., Pagano, J., Bornkamm, G., and Henle, W., 1977, Lymphoma in Cotton-top marmosets after inoculation with Epstein-Barr virus: Tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses, J. Exp. Med. 145:948–967.
Miller, G., Grogan, E., Heston, L., Robinson, F., and Smith, D., 1981, Epstein-Barr viral DNA: Infectivity for human placental cells, Science 211:452–455.
Minowada, J., Klein, G., Clifford, P., Klein, E., and Moore, G.E., 1967, Studies of Burkitt lymphoma Cells. I. Establishment of a Cell line (B35M) and its Characteristics, Cancer 20:1439–1437.
Misko, I., Moss, D., and Pope, J., 1980, HLA antigen restriction of T lymphocyte Cytotoxicity to Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 77:4247–4250.
Mitelman, F., Andersson-Anvret, M., Brandt, L., Catovsky, D., Klein, G., Manolov, G., Manolova, Y., Mark-Vendel, E., and Nilsson, P.G., 1979a, Reciprocal 8; 14 translocation in EBV-negative B-cell acute lymphocyte leukemia with Burkitt-type cells, Int. J. Cancer 24:27–33.
Mitelman, F., Klein, G., Andersson-Anvret, M., Forsby, N., and Johansson, B., 1979b, 14q + marker Chromosome in an EBV-genome-negative lymph node without signs of malignancy in a patient with EBV-genome-positive nasopharyngeal Carcinoma, Int. J. Cancer 23:32–36.
Miyoshi, I., Hiraki, S., Kimura, L, Myamoto, K., and Sato, J., 1979, 2/8 translocation in a Japanese Burkitt’s lymphoma, Experientia 35:742.
Mizuno, F., Aya, T., and Osato, T., 1976, Growth in semisolid agar medium of human Cord leukocytes freshly transformed by Epstein-Barr virus, J. Natl. Cancer Inst. 56:171–173.
Moar, M.H., and Klein, G., 1979, Abortive expression of the Epstein-Barr virus (EBV) Cycle in a variety of EBV DNA-containing Cell lines as reflected by nucleic acid hybridization in situ, Int. J. Cancer 24:679–687.
Moore, G.E., Grace, J.T., Jr., Citron, P., Gerner, R.E., and Burns, A., 1966, Leukocyte Cultures of patients with leukemia and lymphomas, N. Y. State J. Med. 66:2757–2764.
Moore, G.E., Gerner, R.E., and Franklin, H.A., 1967, Culture of normal leukocytes, J. Am. Med. Assoc. 199:519–524.
Moore, G.E., Kitamura, H., and Toshima, S., 1968, Morphology of Cultured hematopoietic cells, Cancer 22:245–267.
Morgan, D.G., Niederman, J.C., Miller, G., Smith, H.W., and Dowaliby, J.M., 1979, Site of Epstein-Barr virus replication in the oropharynx, Lancet 1:1154–1157.
Moses, H.L., Glade, P.R., Kasel, J.A., Rosenthal, A.S., Hirshaut, Y., and Chessin, L.N., 1968, Infectious mononucleosis: Detection of herpes-like virus and reticular aggregates of small Cytoplasmic particles in Continuous lymphoid Cell lines derived from peripheral blood, Proc. Natl Acad. Sci. U.S.A. 60:489–496.
Moss, D.J., and Pope, J.H., 1972, Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro, J. Gen. Virol. 17:233–236.
Moss, D., Rickinson, A., and Pope, J., 1978, Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in Cultures of seropositive donor leukocytes, Int. J. Cancer 22:662–668.
Moss, D.J., Rickinson, A., and Pope, J., 1979, Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of Cytotoxic T cells in virus-infected leukocyte Cultures, Int. J. Cancer 23:618–625.
Nadkarni, J.S., Nadkarni, J.J., Clifford, P., Manolov, G., Fenyö, E.M., and Klein, E., 1969, Characteristics of new Cell lines derived from Burkitt lymphomas, Cancer 23:64–79.
Nilsson, K., 1971, High frequency-establishment of human immunoglobulin producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood, Int. J. Cancer 8:432–442.
Nilsson, K., 1979, The nature of lymphoid Cell lines and their relationship to the virus, in: The Epstein-Barr Virus (M.A. Epstein and B.G. Achong, eds.), pp. 225–281, Springer-Verlag, Berlin, Heidelberg, New York.
Nilsson, K., and Ponten, J., 1975, Classification and biological nature of established human hematopoietic Cell lines, Int. J. Cancer 15:321–341.
Nilsson, K., Bennich, H., Johansson, S.G.O., and Ponten, J., 1970, Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) Cell lines from an IgE myeloma patient, Clin. Exp. Immunol. 7:477–459.
Nilsson, K., Klein, G., Henle, G., and Henle, W., 1971, The establishment of lymphoblastoid Cell lines and its dependence on EBV, Int. J. Cancer 8:443–450.
Nilsson, K., Evrin, P.R., and Welsh, K.L, 1974, Production of β2-microglobulin by normal and malignant human Cell lines and peripheral lymphocytes, Transplantation 21:53–84.
Nilsson, K., Anderson, L.C., Gahmberg, C.G., and Wigzell, H., 1977a, Surface glycoprotein patterns of normal and malignant human lymphoid Cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid Cell lines, Int. J. Cancer 20:708–718.
Nilsson, K., Giovanella, B.C., Stehlin, J.S., and Klein, G., 1977b, Tumorigenicity of human hematopoietic Cell lines in athymic nude mice, Int. J. Cancer 19:337–342.
Nyormi, O., Thorley-Lawson, D.A., Elkington, J., and Strominger, J.L., 1976, Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production, Proc. Natl. Acad. Sci. U.S.A. 73:1745–1748.
Okada, H., and Baba, T., 1974, Rosette formation of human erythrocytes on Cultured cells of tumor origin and activation of Complement by Cell membrane, Nature (London) 248:521–522.
Ostberg, L., Rask, L., Nilsson, K., and Peterson, P.A., 1975, Independent expression of the two HL-A antigen polypeptide Chains, Eur. J. Immunol. 5:462–468.
Osunkoya, B.O., McFarlane, H., Luzatto, L., Udeozo, I.O.K., Mottram, F.C., Williams, A.I.O., and Ngu, V.A., 1968, Immunoglobulin synthesis by fresh cells and established Cell lines from Burkitt’s lymphoma, Immunology 14:851–860.
Papermaster, V.M., Papermaster, B.W., and Moore, G.E., 1969, Histocompatibility antigens of human lymphocytes in long term Culture, Fed. Proc. Fed. Am. Soc. Exp. Biol. 28:379.
Pattengale, P.K., Smith, R.W., and Gerber, P., 1974, B-cell Characteristics of human peripheral and Cord blood lymphocytes transformed by Epstein-Barr virus, J. Natl. Cancer Inst. 52:1081–1086.
Philip, P., Krogh Jensen, M., and Pallesen, G., 1977, Marker Chromosome 14q+ in non-endemic Burkitt’s lymphoma, Cancer 39:1495–1499.
Pious, D., Bodmer, J., and Bodmer, W., 1974, Antigenic expression and Cross reactions in HL-A variants of lymphoid Cell lines, Tissue Antigens 4:247–256.
Pizzo, P.A., Magrath, LT., Chattopadhyay, S.K., Biggar, R.J., and Gerber, P., 1978, A new tumour-derived transforming strain of Epstein-Barr virus, Nature (London) 272:629–631.
Pope, J.H., 1967, Establishment of Cell lines from peripheral leukocytes in infectious mononucleosis, Nature (London) 216:810–811.
Pope, J.H., Achong, B.G., and Epstein, M.A., 1967, Burkitt lymphomas in New Guinea: Establishment of a line of lymphoblasts in vitro and description of their fine structure, J. Natl. Cancer Inst. 39:933–945.
Pope, J.H., Horne, M.K., and Scott, W., 1968, Transformation of foetal human leucocytes in vitro by filtrates of a human leukemic Cell line Containing herpes-like virus, Int. J. Cancer 3:857–866.
Pope, J.H., Horne, M.K., and Scott, W., 1969, Identification of the filtrable leukocyte-transforming factor of QIMR,WIL cells as herpes-like virus, Int. J. Cancer 4:255–260.
Pope, J.H., Scott, W., and Moss, D.J., 1974, Cell relationships in transformation of human leukocytes by Epstein-Barr virus, Int. J. Cancer 14:122–129.
Premkumar, E., Singer, P.A., and Williamson, A.R., 1975, A human lymphoid Cell line secreting immunoglobulin G and retaining immunoglobulin M in the plasma membrane, Cell 5:87–92.
Pulvertaft, R.J.V., 1964a, Cytology of Burkitt’s tumour (African lymphoma), Lancet 1:238–240.
Pulvertaft, R.J.V., 1964b, Phytohemagglutinin in relation to Burkitt’s tumor (African lymphoma), Lancet 2:552–553.
Purtilo, D.T., 1980, Epstein-Barr virus induced oncogenesis in immunodeficient individuals, Lancet 1:300–303.
Qualtiere, L.F., and Pearson, G.R., 1979, Epstein-Barr virus-induced membrane antigens: Immunochemical Characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells, Int. J. Cancer 23:808–817.
Rabin, H., Neubauer, R., Hopkins, R., and Levy, B., 1977, Characterization of lymphoid Cell lines established from multiple Epstein-Barr virus (EBV)-induced lymphomas in a Cotton-topped marmoset, Int. J. Cancer 20:44–50.
Rabson, A.S., O’Conor, G.T., Baron, S., Whang, J.J., and Legallais, F.Y., 1966, Morphologic, Cytogenetic and virologie studies in vitro of a malignant lymphoma from an African Child, Int. J. Cancer 1:89–106.
Ragona, G., Ernberg, I., and Klein, G., 1980, Induction and biological Characterization of the Epstein-Barr virus (EBV) Carried by the Jijoye lymphoma line, Virology 101:553–557.
Recher, L., Sinkovics, J.G., Sykes, J.A., and Whitescarver, J., 1969, Electron microscopic studies of suspension Cultures derived from human leukemic and non-leukemic sources, Cancer Res. 29:271–285.
Reedman, B.M., and Klein, G., 1973, Cellular localization of an Epstein-Barr virus (EBV)-associated Complement-fixing antigen in producer and non-producer lymphoblastoid Cell lines, Int. J. Cancer 11:499–520.
Rickinson, A.B., Jarvis, J.E., Crawford, D.H., and Epstein, M.A., 1974, Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis, Int. J. Cancer 14:704–715.
Rickinson, A.B., Crawford, D., and Epstein, M.A., 1977, Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients, Clin. Exp. Immunol. 28:72–79.
Rickinson, A., Moss, D., and Pope, J., 1979, Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte Cultures, Int. J. Cancer 23:610–717.
Rickinson, A., Moss, D., Pope, J., and Ahlberg, N., 1980a, Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in Convalescent infectious mononucleosis patients, Int. J. Cancer 25:59–65.
Rickinson, A., Wallace, L., and Epstein, M., 1980b, HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells, Nature (London) 283:865–867.
Rickinson, A., Moss, D., Wallace, L., Misko, I., Epstein, M., and Pope, J., 1981, Long-term T-cell-mediated immunity to Epstein-Barr virus, Cancer Res. 41:4216–4221.
Robinson, J., and Miller, G., 1975, Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical Cord blood, J. Virol. 15:1065–1072.
Robinson, J., and Smith, D., 1981, Infection of human B-lymphocytes with high multiplicities of Epstein-Barr virus: Kinetics of EBNA expression, Cellular DNA synthesis and mitosis, Virology 109:336–343.
Robinson, J.E., Andiman, W.A., Henderson, E., and Miller, G., 1977, Host determined differences in expression of surface marker Characteristics on human and simian lymphoblastoid Cell lines transformed by Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 74:749–753.
Robinson, J., Frank, A., Henderson, E., Schweitzer, J., and Miller, G., 1979, Surface markers and size of lymphocytes in human umbilical Cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr virus, Infect. Immun. 26:225–231.
Robinson, J., Brown, N., Andiman, W., Halliday, K., Francke, U., Robert, M., Andersson-Anvret, M., Horstmann, D., and Miller, G., 1980a, Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus, N. Engl. J. Med. 302:1293–1297.
Robinson, J., Smith, D., and Niederman, J., 1980b, Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis, Nature (London) 287:334–335.
Robinson, J., Smith, D., and Niederman, J., 1981, Plasmacytic differentiation of Circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis, J. Exp. Med. 153:235–244.
Rocchi, G., and Hewetson, J.F., 1973, A practical and quantitative microtest for detection of neutralizing antibodies against Epstein-Barr virus, J. Gen. Virol. 13:385–391.
Rocchi, G., de Felici, A., Ragona, G., and Heinz, A., 1977, Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis, N. Engl. J. Med. 296:132–134.
Rogentine, G.N., and Gerber, P., 1969, HL-A antigens of human lymphoid cells in long term tissue Culture, Transplantation 8:28–37.
Rosen, A., Gergely, P., Jondal, M., Klein, G., and Britton, S., 1977, Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro, Nature (London) 267:52–56.
Rosenthal, K., Yamovich, S., Inbar, M., and Strominger, J.L., 1978, Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid Cells: An assay for early events in viral infection, Proc. Natl. Acad. Sci. U.S.A. 75:5076–5080.
Royston, I., Sullivan, J., Periman, P., and Perlin, E., 1975, Cell-mediated immunity to Ep-stein-Barr-virus transformed lymphoblastoid cells in acute infectious mononucleosis, N. Engl. J. Med. 293:1159–1163.
Rymo, L., 1979, Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells, J. Virol. 32:8–18.
Saemundsen, A.K., Kallin, B., and Klein, G., 1980, Effect of n-butyrate on Cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus, Virology 107:557–561.
Sairenji, T., and Hinuma, Y., 1973, Modes of Epstein-Barr virus in human floating Cell lines, Gann 64:583–590.
Sairenji, T., and Hinuma, Y., 1975, Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier Cell line, J. Natl. Cancer Inst. 55:339–343.
Sairenji, T., and Hinuma, Y., 1980, Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma Cell line, Jijoye, Int. J. Cancer 26:337–342.
Schneider, U., and zur Hausen, H. 1975, Epstein-Barr virus-induced transformation of human leukocytes after Cell fractionation, Int. J. Cancer 15:59–66.
Seeley, J., Svedmyr, E., Wieland, O., Klein, G., Möller, E., Eriksson, E., Andersson, K., and van der Waal, L., 1981, Epstein-Barr selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens, J. Immunol. 127:293–300.
Seigneurin, J.M., Vuillaume, M., Lenoir, G., and de Thé G., 1977, Replication of Epstein-Barr virus: Ultrastructural and immunofluorescent studies of P3HR-I superinfected Raji cells, J. Virol. 24:836–845.
Shapiro, I.M., Andersson-Anvret, M., and Klein, G., 1978, Polyploidization of Epstein-Barr virus (EBV) Carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-I virus superinfection or iododeoxyuridine treatment, Inter-virology 10:94–101.
Sherr, C.J., Schenkein, I., and Uhr, J.W., 1971, Synthesis and intracellular transport of immunoglobulin in secretory and nonsecretory cells, Ann. N. Y. Acad. Sci. 190:250–267.
Shevach, E.M., Herberman, R., Frank, M.M., and Green, I., 1972, Receptors for Complement and immunoglobulin on human leukemic cells and human lymphoblastoid Cell lines, J. Clin. Invest. 51:1933–1938.
Shope, T., and Miller, G., 1973, Epstein-Barr virus: Heterophile responses in squirrel monkeys inoculated with virus transformed autologous leukocytes, J. Exp. Med. 137:140–147.
Shope, T., Dechairo, D., and Miller, G., 1973, Malignant lymphoma in Cotton-top marmosets after inoculation with Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 70:2487–2491.
Siegert, W., Moar, M.H., Bell, C., and Klein, G., 1977, Demonstration of Complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography, Cell. Immunol. 31:234–241.
Southam, C.M., Burchenal, J.H., Clarkson, B., Tanzi, A., Mackey, R., and McComb, V., 1969a, Heterotransplantation of human Cell lines from Burkitt’s tumors and acute leukemia into newborn rats, Cancer 23:281–299.
Southam, C.M., Burchenal, J.H., Clarkson, B., Tanzi, A., Mackey, R., and McComb, V., 1969b, Heterotransplantability of human Cell lines derived from leukemia and lymphomas into immunologically tolerant rats, Cancer 24:211–222.
Steel, C.M., and Hardy, D.A., 1970, Evidence of altered antigenicity in Cultured lymphoid cells from patients with infectious mononucleosis, Lancet 1:1322–1323.
Steel, C.M., McBeath, S., and O’Riordan, M.L., 1971, Human lymphoblastoid Cell lines. II. Cytogenetic studies, J. Natl. Cancer Inst. 47:1203–1214.
Steel, C.M., Hardy, D.A., Ling, N.R., Dick, H.M., Macintosh, P., and Crichton, W.B., 1973, The interaction of normal lymphocytes and cells from lymphoid Cell lines. III. Studies on activation in an autochthonous system, Immunology 24:177–189.
Steel, C.M., Evans, J., Joss, A.W.L., and Arthus, M.E., 1974, Antibody activity associated with immunoglobulins secreted by human lymphoblastoid Cell lines, Nature (London) 252:604–605.
Steinitz, M., Klein, G., 1975, Comparison between growth Characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro, Proc. Natl Acad. Sci. U.S.A. 72:3518–3520.
Steinitz, M., Klein, G., Koskimies, S., and Mäkelä, O., 1977, EB virus-induced B lymphocyte Cell lines producing specific antibody, Nature (London) 269:429–422.
Steinitz, M., Bakacs, T., and Klein, G., 1978, Interaction of the B95–8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes, Int. J. Cancer 22:251–257.
Steinitz, M., Koskimies, S., Klein, G., and Mäkelä, O., 1979a, Establishment of specific antibody producing human lines by antigen pre-selection and Epstein-Barr (EBV)-trans-formation, J. Clin. Lab. Immunol. 2:1–7.
Steinitz, M., Seppälä, I., Eichmann, K., and Klein, G., 1979b, Establishment of a human lymphoblastoid Cell line with specific antibody production against Group A streptococcal Carbohydrate, Immunobiology 156:41–47.
Stewart, S.E., Lovelace, E., Whang, J.J., and Ngu, V.A., 1965, Burkitt tumor, tissue Culture, Cytogenetic and virus studies, J. Natl. Cancer Inst. 34:319–327.
Strauch, B., Siegel, N., Andrews, L., and Miller, G., 1974, Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs, Lancet 1:234–237.
Strominger, J., and Thorley-Lawson, D., 1979, Early events in transformation of human lymphocytes by the virus, in: The Epstein-Barr Virus (M.A. Epstein, and B.G. Achong, eds.), pp. 185–204, Springer-Verlag, Berlin, Heidelberg, New York.
Sugamura, K., and Hinuma, Y., 1980, In vitro induction of Cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed Cells: Kinetics of autologous restimulation, J. Immunol. 124:1045–1049.
Sugden, B., 1977, Comparison of Epstein-Barr viral DNA’s in Burkitt lymphoma biopsy cells and in cells Clonally transformed in vitro, Proc. Natl. Acad. Sci. U.S.A. 74:4651–4655.
Sugden, B., and Mark, W., 1977, Clonal transformation of adult human leukocytes by Epstein-Barr virus, J. Virol. 23:503–508.
Sugden, B., Phelps, M., and Domoradzki, J., 1979, Epstein-Barr virus DNA is amplified in transformed lymphocytes, J. Virol. 31:590–595.
Sullivan, J.L., Byron, K.S., Brewster, F.E., and Purtilo, D.T., 1980, Deficient natural killer Cell activity in the X-linked lymphoproliferative syndrome, Science 210:543–545.
Summers, W.C., and Klein, G., 1976, Inhibition of EBV DNA synthesis and late gene expression by phosphonoacetic acid, J. Virol. 18:151–155.
Svedmyr, E., and Jondal, M., 1975, Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 72:1622–1626.
Svedmyr, E., Jondal, M., Henle, W., Weiland, O., Rombo, L., and Klein, G., 1978, EBV specific killer T cells and serologic responses after onset of infectious mononucleosis, J. Clin. Lab. Immunol. 1:225–232.
Takada, K., and Osato, T., 1979, Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis, Intervirology 11:30–39.
Takahashi, M., Yagi, Y., Moore, G.F., and Pressman, D., 1969a, Pattern of immunoglobulin production in individual cells of human hematopoietic origin in established Culture, J. Immunol. 102:1274–1283.
Takahashi, M., Tanigaki, N., Yagi, Y., Moore, G.E., and Pressman, D., 1969b, Immunoglobulin production in Cloned sublines of a human lymphocytoid Cell line, J. Immunol. 102:1388–1393.
Tanaka, Y., Sugamura, K., Hinuma, Y., Sato, H., and Okochi, K., 1980, Memory of Ep-stein-Barr virus-specific Cytotoxic T cells in normal seropositive adults as revealed by an in vitro restimulation method, J. Immunol. 125:1426–1431.
Tanigaki, N., Yagi, Y., Moore, G.E., and Pressman, D., 1966, Immunoglobulin production in human leukemia Cell lines, J. Immunol. 97:634–646.
Theofilopoulos, A.N., and Perrin, L.H., 1977, Lysis of human Cultured lymphoblastoid cells by Cell-induced activation of the properdin pathway, Science 195:878–880.
Thestrup-Pedersen, K., Esmann, V., Bisballe, S., Jensen, J.R., Pallesen, G., Hastrup, J., Madsen, M., Thorling, K., Grazia-Masucci, M., Saemundsen, A.K., and Ernberg, I., 1980, Epstein-Barr-virus-induced lymphoproliferative disorder Converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible Chromosomal defect, Lancet 2:997–1001.
Thorley-Lawson, D.A., 1979, Characterization of Cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells, Cell 16:33–42.
Thorley-Lawson, D., and Strominger, J.L., 1976, Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid, Nature (London) 263:332–334.
Thorley-Lawson, D., and Strominger, J., 1978, Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus, Virology 86:423–431.
Thorley-Lawson, D., Chess, L., and Strominger, F., 1977, Suppression of in vitro Epstein-Barr virus infection: A new role for adult human T lymphocytes, J. Exp. Med. 146:495–508.
Tomkins, G.A., 1968, Chromosome studies on Cultured lymphoblastoid cells from Cases of New Guinea Burkitt lymphoma, myeloblastic and lymphoblastic leukemia and infectious mononucleosis, Int. J. Cancer 3:644–653.
Tovey, M.G., Lenoir, G., Bergen-Lours, J., 1978, Activation of latent Epstein-Barr virus by antibody to human IgM, Nature (London) 276:270–272.
Traul, K.A., Stephens, R., Gerber, P., and Peterson, W.D., 1977, Productive Epstein-Barr viral infection of the human lymphoblastoid Cell line, 6410, with release of early antigen inducing and transforming virus, Int. J. Cancer 20:247–255.
Trowbridge, I.S., Hyman, R., and Klein, G., 1977, Human B Cell line deficient in the expression of B Cell-specific glycoproteins (GP 27, 35), Eur. J. Immunol. 7:640–645.
Trumper, P.A., Epstein, M.A., Giovanella, B.C., and Finerty, S., 1977, Isolation of infectious EB virus from the epithelial tumor cells of nasopharyngeal Carcinoma, Int. J. Cancer 20:655–662.
Van Beek, W., Nilsson, K., Klein, G., and Emmelot, P., 1979, Cell surface glycoprotein Changes in Epstein-Barr virus-positive and -negative human hematopoietic Cell lines, Int. I Cancer 23:464–473.
Van Boxel, J.A., and Buell, D.N., 1974, IgD on Cell membranes of human lymphoid Cell lines with multiple immunoglobulin Classes, Nature (London) 251:443–444.
Van den Berg, H., Parloir, H., Gossy, S., Englebienne, V., Cornu, G., and Sokal, G., 1979, Variant translocation in Burkitt lymphoma, Cancer Genet. Cytogenet. 1:9–14.
Van de Stouwe, R., Kunkel, H., Halper, J., and Weksler, M., 1977, Autologous mixed lymphocyte Culture reactions and generation of Cytotoxic T cells, J. Exp. Med. 146:1809–1814.
Van Furth, R., Gorte, H., Nadkarni, J.S., Klein, E., and Clifford, P., 1972, Synthesis of immunoglobulins by biopsied tissues and Cell lines from Burkitt’s lymphoma, Immunology 22:847–857.
Volsky, D.J., Shapiro, I.M., and Klein, G., 1980, Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression, Proc. Natl. Acad. Sci. U.S.A. 77:5453–5457.
Vonka, V., and Kutinova, L., 1973, Increase of EB virus positive cells in Cultured Burkitt lymphoma cells after short-time exposure to heat, Neoplasma 20:349–352.
Vonka, V., Kutinova, L., Drobnik, F., and Bräuerova, J., 1972, Increase of Epstein-Barr virus positive cells in EB 3 Cultures after treatment with Cisdichlorodiammine-platinum (11), J. Natl. Cancer Inst. 48:1277–1281.
Wakefield, J.D., Thorbecke, G. J., Old, L.J., and Boyse, E.A., 1967, Production of immunoglobulins and their subunits by human tissue Culture Cell lines, J. Immunol. 99:308–319.
Weksler, M., 1976, Lymphocyte transformation induced by autologous Cells. III. Lymphob-last-induced lymphocyte stimulation does not Correlate with EB viral antigen expression or immunity, J. Immunol. 116:310–314.
Welsh, K.I., Dorval, G., Nilsson, K., Clements, G., and Wigzell, H., 1977, Quantitation of ß2-microglobulin and HLA on the surface of human Cells. II. In vitro Cell lines and their hybrids, Scand. J. Immunol. 6:265–271.
Werner, J., Wolf, H., Apodaca, J., and zur Hausen, H., 1975, Lymphoproliferative disease in a Cotton-top marmoset after inoculation with infectious mononucleosis-derived Ep-stein-Barr virus, Int. J. Cancer 15:1000–1008.
Wernet, P., 1976, Human la-type alloantigens, methods of detection, aspects of Chemistry and biology, markers of disease states, Transplant. Rev. 30:271–298.
Whang-Peng, J., Gerber, P., and Knutsen, T., 1970, So-called C marker Chromosome and Epstein-Barr virus, J. Natl. Cancer Inst. 45:831–839.
Wilson, G., and Miller, G., 1979, Recovery of Epstein-Barr virus from nonproducer human lymphoid Cell lines, Virology 95:351–358.
Yajima, Y., and Nonoyama, M., 1976, Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of non-infectious virus particles in superinfected Raji cells, J. Virol. 19:187–194.
Yamamoto, N., and Hinuma, Y., 1976, Clonal transformation of human leukocytes by Epstein-Barr virus in soft agar, Int. J. Cancer 17:191–196.
Yata, J., Desgranges, C., Nakagawa, T., Favre, M.D., and de Thé, G., 1975, Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in Cordblood lymphocytes infected by Epstein-Barr virus (EBV), Int. J. Cancer 15:377–384.
Yefenof, E., and Klein, G., 1977, Membrane receptor stripping Confirms the association between EBV receptors and Complement receptors on the surface of human B lymphoma lines, Int. J. Cancer 20:347–352.
Yefenof, E., Klein, G., Jondal, M., and Oldstone, M.B.A., 1976, Surface markers on human B- and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and Complement receptors on the surface of lymphoid Cell lines, Int. J. Cancer 17:693–700.
Yefenof, E., Klein, G., and Kvarnung, K., 1977, Relationships between Complement activation, Complement binding and EBV absorption by human hematopoietic Cell lines, Cell. Immunol. 31:225–233.
Yeh, C.G., Robinson, J., and Faulk, W.P., 1982, Antigens of Epstein-Barr virus, infected marmoset lymphocytes, identification on marmoset erythrocytes, human extra-embryonic membranes and transformed cells (submitted).
Zech, L., Haglund, U., Nilsson, K., and Klein, G., 1976, Characteristic Chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas, Int. J. Cancer 17:47–56.
Zerbini, M., and Ernberg, I., 1982, The Epstein-Barr virus (EBV): Infection and growth stimulating effect in human B lymphocytes (submitted).
Zeve, V.H., Lucas, S.L., and Manaker, R.A., 1966, Continuous Cell Culture from a patient with Chronic myelogenous leukemia. II. Detection of a herpes-like virus by electron-microscopy, J. Natl. Cancer Inst. 37:761–773.
Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Sanesson, L., 1970, EBV DNA in biopsies of Burkitt tumours and anaplastic Carcinomas of the nasopharynx, Nature (London) 228:1056–1058.
Zur Hausen, H., Diehl, V., Wolf, H., Schulte-Holthausen, H., and Schneider, U., 1972, Occurrence of Epstein-Barr virus genomes in human lymphoblastoid Cell lines, Nature (London) New Biol. 237:189–190.
Zur Hausen, H., O’Neill, F.J., Freese, U.K., and Hecher, E., 1978, Persisting oncogenic herpesvirus induced by tumor promoter TPA, Nature (London) 272:373–375.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Robinson, J.E., Miller, G. (1982). Biology of Lymphoid Cells Transformed by Epstein—Barr Virus. In: Roizman, B. (eds) The Herpesviruses. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4163-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4163-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4165-9
Online ISBN: 978-1-4684-4163-5
eBook Packages: Springer Book Archive